Tolar, M., Abushakra, S., Hey, J. A., Porsteinsson, A., & Sabbagh, M. (2020). Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval. Alzheimers Res Ther.

Tolar, Martin, Susan Abushakra, John A. Hey, Anton Porsteinsson, i Marwan Sabbagh. "Aducanumab, Gantenerumab, BAN2401, and ALZ-801—the First Wave of Amyloid-targeting Drugs for Alzheimer’s Disease With Potential for Near Term Approval." Alzheimers Res Ther 2020.

Tolar, Martin, et al. "Aducanumab, Gantenerumab, BAN2401, and ALZ-801—the First Wave of Amyloid-targeting Drugs for Alzheimer’s Disease With Potential for Near Term Approval." Alzheimers Res Ther 2020.